Carlos Andrés Jimenez-Ruiz , José Ignacio de Granda-Orive , Carlos Rábade Castedo , Harold J. Farber , Angélica Ocampo , Susana Luhning , Beatriz Raboso-Moreno , Lola del Puerto-Garcia , Daniel Buljubasich , Manuel Conrado Pacheco-Gallego , José Antonio Castillo-Vizueta , Rosa Mirambeaux-Villalona , Marcos García-Rueda , Juan Antonio Riesco-Miranda , Ángela Ramos-Pinedo , Jaime Signes-Costa , Ledys Blanquicett-Barrios , Eva de Higes-Martinez , Catalina Casillas-Suarez , Concepción Rodríguez-García , Maribel Cristóbal-Fernández
{"title":"使用新的烟草和尼古丁产品作为一种减少危害的策略:对证据的批判性审查","authors":"Carlos Andrés Jimenez-Ruiz , José Ignacio de Granda-Orive , Carlos Rábade Castedo , Harold J. Farber , Angélica Ocampo , Susana Luhning , Beatriz Raboso-Moreno , Lola del Puerto-Garcia , Daniel Buljubasich , Manuel Conrado Pacheco-Gallego , José Antonio Castillo-Vizueta , Rosa Mirambeaux-Villalona , Marcos García-Rueda , Juan Antonio Riesco-Miranda , Ángela Ramos-Pinedo , Jaime Signes-Costa , Ledys Blanquicett-Barrios , Eva de Higes-Martinez , Catalina Casillas-Suarez , Concepción Rodríguez-García , Maribel Cristóbal-Fernández","doi":"10.1016/j.opresp.2025.100534","DOIUrl":null,"url":null,"abstract":"<div><div>The sale, distribution, and indiscriminate use of new tobacco and nicotine products have multiplied. The most relevant products are: electronic cigarettes (ECs), heated tobacco (HT), and nicotine pouches (NPs). From the tobacco industry and its related health sectors, and even from some health institutions with no clear influence from this industry, the use of all these devices is being promoted as an excellent harm reduction strategy for those conventional tobacco smokers who do not want to or cannot quit smoking. This paper reviewed the lack of scientific evidence of this strategy.</div></div>","PeriodicalId":34317,"journal":{"name":"Open Respiratory Archives","volume":"8 2","pages":"Article 100534"},"PeriodicalIF":0.0000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Use of New Tobacco and Nicotine Products as a Harm Reduction Strategy: A Critical Review of the Evidence\",\"authors\":\"Carlos Andrés Jimenez-Ruiz , José Ignacio de Granda-Orive , Carlos Rábade Castedo , Harold J. Farber , Angélica Ocampo , Susana Luhning , Beatriz Raboso-Moreno , Lola del Puerto-Garcia , Daniel Buljubasich , Manuel Conrado Pacheco-Gallego , José Antonio Castillo-Vizueta , Rosa Mirambeaux-Villalona , Marcos García-Rueda , Juan Antonio Riesco-Miranda , Ángela Ramos-Pinedo , Jaime Signes-Costa , Ledys Blanquicett-Barrios , Eva de Higes-Martinez , Catalina Casillas-Suarez , Concepción Rodríguez-García , Maribel Cristóbal-Fernández\",\"doi\":\"10.1016/j.opresp.2025.100534\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The sale, distribution, and indiscriminate use of new tobacco and nicotine products have multiplied. The most relevant products are: electronic cigarettes (ECs), heated tobacco (HT), and nicotine pouches (NPs). From the tobacco industry and its related health sectors, and even from some health institutions with no clear influence from this industry, the use of all these devices is being promoted as an excellent harm reduction strategy for those conventional tobacco smokers who do not want to or cannot quit smoking. This paper reviewed the lack of scientific evidence of this strategy.</div></div>\",\"PeriodicalId\":34317,\"journal\":{\"name\":\"Open Respiratory Archives\",\"volume\":\"8 2\",\"pages\":\"Article 100534\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2026-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Respiratory Archives\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2659663625001584\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/12/24 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Respiratory Archives","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2659663625001584","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Use of New Tobacco and Nicotine Products as a Harm Reduction Strategy: A Critical Review of the Evidence
The sale, distribution, and indiscriminate use of new tobacco and nicotine products have multiplied. The most relevant products are: electronic cigarettes (ECs), heated tobacco (HT), and nicotine pouches (NPs). From the tobacco industry and its related health sectors, and even from some health institutions with no clear influence from this industry, the use of all these devices is being promoted as an excellent harm reduction strategy for those conventional tobacco smokers who do not want to or cannot quit smoking. This paper reviewed the lack of scientific evidence of this strategy.